MicroRNA-153 physiologically inhibits expression of amyloid-β precursor protein in cultured human fetal brain cells and is dysregulated in a subset of Alzheimer disease patients.
about
Body fluid biomarkers in Alzheimer's diseaseNeuronal dark matter: the emerging role of microRNAs in neurodegenerationGetting miRNA Therapeutics into the Target Cells for Neurodegenerative Diseases: A Mini-ReviewNovel Nuclear Factor-KappaB Targeting Peptide Suppresses β-Amyloid Induced Inflammatory and Apoptotic Responses in Neuronal CellsNeurobiology of Alzheimer's Disease: Integrated Molecular, Physiological, Anatomical, Biomarker, and Cognitive DimensionsCdk5 activity in the brain - multiple paths of regulation.Epigenetic regulation of adult neural stem cells: implications for Alzheimer's disease.Epigenetic mechanisms during ageing and neurogenesis as novel therapeutic avenues in human brain disorders.MiR-153 targets the nuclear factor-1 family and protects against teratogenic effects of ethanol exposure in fetal neural stem cells.Human primary mixed brain cultures: preparation, differentiation, characterization and application to neuroscience research.Lessons from a BACE1 inhibitor trial: off-site but not off base.The epigenetic dimension of Alzheimer's disease: causal, consequence, or curiosity?Circulating miRNA biomarkers for Alzheimer's diseaseFunctional microRNAs in Alzheimer's disease and cancer: differential regulation of common mechanisms and pathways.Studying micro RNA Function and Dysfunction in Alzheimer's DiseaseMutation in the 3'untranslated region of APP as a genetic determinant of cerebral amyloid angiopathy.Co-regulation of intragenic microRNA miR-153 and its host gene Ia-2 β: identification of miR-153 target genes with functions related to IA-2β in pancreas and brainA study of small RNAs from cerebral neocortex of pathology-verified Alzheimer's disease, dementia with lewy bodies, hippocampal sclerosis, frontotemporal lobar dementia, and non-demented human controls.miRNAs: Key Players in Neurodegenerative Disorders and EpilepsymiR-153-3p, a new bio-target, is involved in the pathogenesis of acute graft-versus-host disease via inhibition of indoleamine- 2,3-dioxygenase.A lentiviral sponge for miR-101 regulates RanBP9 expression and amyloid precursor protein metabolism in hippocampal neurons.MicroRNA-339-5p down-regulates protein expression of β-site amyloid precursor protein-cleaving enzyme 1 (BACE1) in human primary brain cultures and is reduced in brain tissue specimens of Alzheimer disease subjectsA microRNA negative feedback loop downregulates vesicle transport and inhibits fear memory.MicroRNA-29b regulates ethanol-induced neuronal apoptosis in the developing cerebellum through SP1/RAX/PKR cascade.MicroRNAs and neurodegeneration: role and impact.The amyloid precursor protein: a biochemical enigma in brain development, function and disease.MicroRNAs and human diseases: diagnostic and therapeutic potential.Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128.MicroRNAs and Molecular Mechanisms of Neurodegeneration.Targeting MicroRNAs in Prevention and Treatment of Neurodegenerative Disorders.The Ia-2β intronic miRNA, miR-153, is a negative regulator of insulin and dopamine secretion through its effect on the Cacna1c gene in mice.Stress-induced changes in miRNA biogenesis and functioning.Opposite Dysregulation of Fragile-X Mental Retardation Protein and Heteronuclear Ribonucleoprotein C Protein Associates with Enhanced APP Translation in Alzheimer Disease.Modifications and Trafficking of APP in the Pathogenesis of Alzheimer's Disease.Intravenous immunoglobulin (IVIG) treatment exerts antioxidant and neuropreservatory effects in preclinical models of Alzheimer's disease.miR-7 and miR-153 protect neurons against MPP(+)-induced cell death via upregulation of mTOR pathway.Are pulmonary fibrosis and Alzheimer's disease linked? Shared dysregulation of two miRNA species and downstream pathways accompany both disorders.Epigenetic Drug Repositioning for Alzheimer's Disease Based on Epigenetic Targets in Human Interactome.Inhibition of microRNA-153 protects neurons against ischemia/reperfusion injury in an oxygen-glucose deprivation and reoxygenation cellular model by regulating Nrf2/HO-1 signaling.The Role of microRNAs in Alzheimer's Disease and Their Therapeutic Potentials.
P2860
Q26830098-EBDA369C-8BF5-4DF8-9B81-54646BFB43DDQ26859224-9478AC51-5A38-4F6B-87D4-8192695DBACFQ28079707-9F355462-6E87-44CE-9B85-015CD5F98532Q28597074-AB496C0F-1C0D-493F-9839-32DBEA60D3E6Q30998279-EC950D7D-F43D-4D62-A999-904DC8E08C12Q33687591-510DDA95-30AE-4DA4-B185-C3493056D603Q33841944-C68744F3-0EE1-4EA0-B081-E7A1291F6085Q33858861-46C8FB8A-F95B-4CDE-8EF1-F30D5D37AA18Q34048818-2CD2C508-1737-4CFF-826F-F3B5B629B48CQ34272943-72FA3F57-E247-416B-8BBD-11702384ABD6Q34381433-7FBE984B-6481-4AD0-8592-C05D9372C1F8Q34426210-CF645BF1-D804-459F-A2EB-694322592DDCQ34904013-064B66AB-739F-4C69-9EBA-96DBC885260CQ36540471-AFE07C41-F8BE-4F29-AD89-FAAD0131508CQ36589571-DC51A9AF-F192-490F-B91C-2C0272BEE9C5Q36695844-563CAB08-45D7-4063-8094-C451AE0E11AFQ36898059-0BE2DE63-CFAA-4EB8-9F75-08840F31711DQ37122270-041967B4-C20D-4786-85D3-14E4524F70BDQ37535111-55187E32-CAEB-4CE0-B4A6-34F5C26D4192Q37565461-FE85AD5B-EA65-4487-88A3-280155B0AB00Q37581560-DDBB563B-A572-4F8B-BC71-4D9D144EB12DQ37596385-ECB64A17-3F7F-4512-BE07-22321F3EF1ABQ37626724-BC954406-B8C3-4E75-ABF3-CAD7BCE81447Q37683323-7A49C250-F93E-4312-81EF-75138664EC59Q38048423-C14FBC60-307D-4072-9831-08ED3E3F64D4Q38107684-D99B4B52-7D00-4449-9CA5-BA66B2995DAAQ38184973-0BD789E2-04D6-4D31-B2B9-0BC0550E7BD6Q38189850-C58727F5-C9B9-484D-9AAD-17E44738C07AQ38202497-9F633D15-2D79-4AAD-B967-A00BE6350039Q38584755-774EEB36-FA4C-4133-839A-36B075D1447AQ38856816-157362D4-980A-4B4B-BC97-E78D8D06DC4AQ39440775-4DCDF64B-5C7F-4E5F-9AE4-86D6A91A1262Q40863954-0371B4C3-2D4E-427A-B121-69B85FF649A9Q41665323-8D012180-B0C0-4141-B71F-98927E3DE490Q41955747-F6ADD760-20C2-49BD-9095-113212E6B956Q42719079-DCCC4305-D415-4F60-AB6D-E1E49CC864FAQ46244961-D6AAD6CA-CDF6-48A6-B548-0F6E47F9FC99Q47288935-51DAED45-C429-4542-BEDF-E3822EBE402CQ51118766-EC38C5DD-E136-4DCE-BFE4-DE1F0CA367FCQ51760979-A1B49D32-38CE-4C93-A6B3-6A40FD1458C8
P2860
MicroRNA-153 physiologically inhibits expression of amyloid-β precursor protein in cultured human fetal brain cells and is dysregulated in a subset of Alzheimer disease patients.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
MicroRNA-153 physiologically i ...... of Alzheimer disease patients.
@ast
MicroRNA-153 physiologically i ...... of Alzheimer disease patients.
@en
MicroRNA-153 physiologically i ...... of Alzheimer disease patients.
@nl
type
label
MicroRNA-153 physiologically i ...... of Alzheimer disease patients.
@ast
MicroRNA-153 physiologically i ...... of Alzheimer disease patients.
@en
MicroRNA-153 physiologically i ...... of Alzheimer disease patients.
@nl
prefLabel
MicroRNA-153 physiologically i ...... of Alzheimer disease patients.
@ast
MicroRNA-153 physiologically i ...... of Alzheimer disease patients.
@en
MicroRNA-153 physiologically i ...... of Alzheimer disease patients.
@nl
P2093
P2860
P921
P356
P1476
MicroRNA-153 physiologically i ...... of Alzheimer disease patients.
@en
P2093
Balmiki Ray
Debomoy K Lahiri
Justin M Long
P2860
P304
31298-31310
P356
10.1074/JBC.M112.366336
P407
P577
2012-06-25T00:00:00Z